Burmeister Jayme Eduardo, Miltersteiner Diego da Rosa, Burmeister Bruna Ortega, Campos Juliana Fernandes
Universidade Luterana do Brasil, Canoas, RS, Brazil.
Arch Endocrinol Metab. 2015 Apr;59(2):137-40. doi: 10.1590/2359-3997000000026. Epub 2015 Apr 1.
To compare the occurrence of hypoglycemia during hemodialysis in chronic kidney disease diabetic patients who present different levels of pre-dialysis glycemia both when using dialysis solutions with and without glucose.
Twenty type 2 diabetic patients in maintenance hemodialysis were submitted to three dialysis sessions (at a 7-day interval each) with dialysis solutions without glucose, with glucose at 55 mg/dL, and at 90 mg/dL subsequently. Blood glucose levels were measured immediately pre-dialysis and at 4 moments during the session, and values under 70 mg/dL were considered as hypoglycemia.
Average pre-dialysis glycemia was lower in those who presented intra-dialytic hypoglycemia than in those who did not, both in glucose-free (140.4 ± 50.7 vs. 277.7 ± 91.0 mg/dL; p = 0.005; 95%CI: 46.4 to 228.1) and in glucose 55 mg/dL (89.5 ± 10.6 vs. 229.7 ± 105.0 mg/dL; p < 0.05; 95%CI: 9.8 to 270.5). In patients with pre-dialysis glycemia under 140 mg/dL, average intradialytic glycemia was significantly lower than pre-dialysis glycemia only when using glucose-free dialysate (p < 0.0001; 95%CI: 29.9 to 56.0 - t-test). Hypoglycemia during dialysis was observed only when using glucose-free or glucose-poor dialysis solutions.
The use of glucose-free or glucose-poor dialysis solution presents a high risk of intradialytic hypoglycemia in diabetic renal patients, especially in those with presumed better glycemic control.
比较在使用含葡萄糖和不含葡萄糖的透析液时,不同透析前血糖水平的慢性肾脏病糖尿病患者在血液透析期间低血糖的发生率。
20例维持性血液透析的2型糖尿病患者接受了三次透析治疗(每次间隔7天),先后使用不含葡萄糖、葡萄糖浓度为55mg/dL和90mg/dL的透析液。在透析前即刻及透析过程中的4个时间点测量血糖水平,血糖值低于70mg/dL被视为低血糖。
发生透析内低血糖的患者透析前平均血糖低于未发生者,在无葡萄糖透析液组(140.4±50.7 vs. 277.7±91.0mg/dL;p = 0.005;95%CI:46.4至228.1)和葡萄糖浓度为55mg/dL的透析液组(89.5±10.6 vs. 229.7±105.0mg/dL;p < 0.05;95%CI:9.8至270.5)均如此。透析前血糖低于140mg/dL的患者,仅在使用无葡萄糖透析液时,透析内平均血糖显著低于透析前血糖(p < 0.0001;95%CI:29.9至56.0 - t检验)。仅在使用无葡萄糖或低糖透析液时观察到透析期间低血糖。
在糖尿病肾病患者中,使用无葡萄糖或低糖透析液会导致透析内低血糖的高风险,尤其是在那些血糖控制可能较好的患者中。